These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Editorial comment to The clinical significance of urine cytology after a radical cystectomy for urothelial cancer. Ukimura O Int J Urol; 2010 Jun; 17(6):532-3. PubMed ID: 20482664 [No Abstract] [Full Text] [Related]
27. Cystectomy in women. Schilling D; Horstmann M; Nagele U; Sievert KD; Stenzl A BJU Int; 2008 Nov; 102(9 Pt B):1289-95. PubMed ID: 19035894 [TBL] [Abstract][Full Text] [Related]
28. Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Montgomery JS; Weizer AZ; Montie JE Urology; 2011 Mar; 77(3):667-8. PubMed ID: 21377013 [No Abstract] [Full Text] [Related]
29. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results. Mills RD; Fleischmann A; Studer UE Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246 [TBL] [Abstract][Full Text] [Related]
30. Estimation of the true number of lymph nodes in lymphadenectomy specimens from radical cystectomy. Jensen JB; Ulhøi BP; Jensen KM Scand J Urol Nephrol; 2009; 43(4):288-92. PubMed ID: 19437191 [TBL] [Abstract][Full Text] [Related]
31. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213 [TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623 [TBL] [Abstract][Full Text] [Related]
34. Editorial comment on: molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Karl A Eur Urol; 2008 Dec; 54(6):1372. PubMed ID: 18486317 [No Abstract] [Full Text] [Related]
35. Editorial comment on: molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Froehner M Eur Urol; 2008 Dec; 54(6):1371. PubMed ID: 18486320 [No Abstract] [Full Text] [Related]
36. Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Donat SM Urology; 2011 Mar; 77(3):666-7; author reply 667. PubMed ID: 21377011 [No Abstract] [Full Text] [Related]
37. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Masood S; Mufti GR Urology; 2008 Oct; 72(4):952; author reply 952. PubMed ID: 18926256 [No Abstract] [Full Text] [Related]
38. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Joudi FN Eur Urol; 2008 Mar; 53(3):579. PubMed ID: 17804153 [No Abstract] [Full Text] [Related]
39. Outcome of patients undergoing radical cystectomy for invasive bladder cancer. Gschwend JE Front Radiat Ther Oncol; 2002; 36():106-17. PubMed ID: 11842741 [No Abstract] [Full Text] [Related]
40. Meticulous pelvic lymphadenectomy in surgical treatment of the invasive bladder cancer: an option or a must? Turner WH; Markwalder R; Perrig S; Studer UE Eur Urol; 1998; 33 Suppl 4():21-2. PubMed ID: 9615204 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]